Virax Biolabs to Participate at 7th European Congress of Immunology
Virax Biolabs Group (VRAX) has announced its participation in the 7th European Congress of Immunology (ECI) from September 1-4, 2024, in Dublin, Ireland. The company will showcase its immune profiling products for research use at Booth C13. Management will be available for discussions with research organizations and potential customers.
The ECI is a prestigious triennial event organized by the European Federation of Immunological Societies (EFIS), attracting over 3,000 delegates in the field of basic and clinical immunology. This year's congress theme is 'Conquering challenges with Immunology', highlighting the importance of immunological research in addressing current health challenges.
Il Gruppo Virax Biolabs (VRAX) ha annunciato la sua partecipazione al 7° Congresso Europeo di Immunologia (ECI) che si terrà dal 1 al 4 settembre 2024 a Dublino, Irlanda. L'azienda presenterà i suoi prodotti di profilazione immunitaria per uso di ricerca presso lo Stand C13. La direzione sarà disponibile per discussioni con organizzazioni di ricerca e potenziali clienti.
Il ECI è un evento prestigioso che si svolge ogni tre anni, organizzato dalla Federazione Europea delle Società Immunologiche (EFIS), e attira oltre 3.000 delegati nel campo dell'immunologia di base e clinica. Il tema di quest'anno è 'Conquistare le sfide con l'Immunologia', sottolineando l'importanza della ricerca immunologica nell'affrontare le attuali sfide sanitarie.
El Grupo Virax Biolabs (VRAX) ha anunciado su participación en el 7° Congreso Europeo de Inmunología (ECI) que se llevará a cabo del 1 al 4 de septiembre de 2024 en Dublín, Irlanda. La empresa mostrará sus productos de perfilado inmunológico para uso en investigación en el Stand C13. La dirección estará disponible para conversar con organizaciones de investigación y posibles clientes.
El ECI es un evento prestigioso que se organiza cada tres años por la Federación Europea de Sociedades Inmunológicas (EFIS), atrayendo a más de 3.000 delegados en el campo de la inmunología básica y clínica. El tema del congreso de este año es 'Superando desafíos con la Inmunología', destacando la importancia de la investigación inmunológica para abordar los actuales desafíos sanitarios.
Virax Biolabs 그룹 (VRAX)이 2024년 9월 1일부터 4일까지 아일랜드 더블린에서 열리는 제7회 유럽 면역학 Congress (ECI)에 참여한다고 발표했습니다. 이 회사는 연구용 면역 프로파일링 제품을 C13 부스에서 선보일 예정이며, 경영진은 연구 기관 및 잠재 고객과의 논의를 위해 자리를 마련할 것입니다.
ECI는 유럽 면역학회 연합( EFIS)이 주최하는 권위 있는 3년마다 열리는 행사로, 기본 및 임상 면역학 분야에서 3,000명 이상의 대표자를 끌어모읍니다. 올해의 컨그레스 주제는 '면역학으로 도전 극복하기'로, 현재의 건강 문제를 해결하는 데 있어 면역학 연구의 중요성을 강조합니다.
Le groupe Virax Biolabs (VRAX) a annoncé sa participation au 7ème Congrès Européen d'Immunologie (ECI) qui se tiendra du 1er au 4 septembre 2024 à Dublin, en Irlande. L'entreprise présentera ses produits de profilage immunitaire à des fins de recherche au stand C13. La direction sera disponible pour des discussions avec des organisations de recherche et des clients potentiels.
Le ECI est un événement prestigieux organisé tous les trois ans par la Fédération Européenne des Sociétés Immunologiques (EFIS), attirant plus de 3 000 délégués dans le domaine de l'immunologie fondamentale et clinique. Le thème du congrès cette année est 'Surmonter les défis avec l'Immunologie', soulignant l'importance de la recherche immunologique pour relever les défis de santé actuels.
Die Virax Biolabs Gruppe (VRAX) hat ihre Teilnahme am 7. Europäischen Immunologie-Kongress (ECI) angekündigt, der vom 1. bis 4. September 2024 in Dublin, Irland, stattfinden wird. Das Unternehmen wird seine Produkte zur Immunprofilierung für Forschungszwecke am Stand C13 präsentieren. Die Geschäftsleitung steht für Gespräche mit Forschungsorganisationen und potenziellen Kunden zur Verfügung.
Der ECI ist eine angesehene triennale Veranstaltung, die von der Europäischen Föderation der Immunologischen Gesellschaften (EFIS) organisiert wird und über 3.000 Delegierte aus den Bereichen der Grundlagen- und klinischen Immunologie anzieht. Das Thema des Kongresses in diesem Jahr lautet 'Herausforderungen mit Immunologie meistern', das die Bedeutung der immunologischen Forschung zur Bewältigung aktueller Gesundheitsprobleme hervorhebt.
- None.
- None.
The Company will be showcasing its portfolio of immune profiling products for research use at Booth C13, and management will be available for discussions with research organizations and potential customers.
The European Congress of Immunology is the triennial joint meeting of all European Federation of Immunological Societies (EFIS). It is now one of the most highly regarded international conferences in the field of basic and clinical immunology, attracting on average more than 3,000 delegates and offering the highest standards in terms of both scientific and social programs. The theme for this year's congress is 'Conquering challenges with Immunology'.
About Virax Biolabs Group Limited
Virax Biolabs Group Limited is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs Group Limited is currently developing T-Cell-based test technologies with the intention of providing an immunology profiling platform. T-Cell testing can be particularly effective in the diagnosis and therapeutics of post-viral syndromes such as Long COVID and other chronic conditions linked to immune dysregulation.
For more information, please visit www.viraxbiolabs.com.
Investor Relations Contact:
Russo Partners, LLC
Nic Johnson and Adanna G. Alexander, Ph.D.
M: 303-482-6405
nic.johnson@russopartnersllc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/virax-biolabs-to-participate-at-7th-european-congress-of-immunology-302234080.html
SOURCE Virax Biolabs
FAQ
When and where is Virax Biolabs (VRAX) participating in the European Congress of Immunology?
What products will Virax Biolabs (VRAX) showcase at the 7th European Congress of Immunology?
How many delegates typically attend the European Congress of Immunology?
What is the theme of the 7th European Congress of Immunology in 2024?
